1 / 17

Access to essential medicines of the future

Access to essential medicines of the future. Bernard Pécoul Director, Campaign for Access to Essential Medicines Médecins Sans Frontières. A sleeping sickness patient, N'dalatando , Angola, 1997. Justice Access to essential medicines as a human right Essential medicines as public goods.

hubert
Download Presentation

Access to essential medicines of the future

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Access to essential medicines of the future Bernard Pécoul Director, Campaign for Access to Essential Medicines Médecins Sans Frontières

  2. A sleeping sickness patient, N'dalatando, Angola, 1997

  3. Justice • Access to essential medicines as a human right • Essential medicines as public goods

  4. Justice

  5. The right of access to essential medicines

  6. Essential medicines as public goods

  7. Future challenges for essential medicines • Some essential medicines still not on the List • Overcome intellectual property barriers to access • Address R&D crisis for medicines for developing country diseases • Maintain the production of essential medicines and secure the market

  8. Some essential medicines still not included on the List

  9. Overcome intellectual property barriers to access

  10. The Effects of Generic Competition Stavudine (d4T) + lamivudine (3TC) + nevirapine (NVP): Lowest world prices per patient per year

  11. Address R&D crisis for medicines for developing country diseases

  12. Research for drugs for neglected diseases 1975 to 1999: 1,393 new chemical entities marketed Tropical diseases: 13 Tuberculosis: 3

  13. Maintain the production of essential medicines and secure the market

More Related